Financial News
Beigene Ltd ADR (NQ: BGNE )
172.85
+1.82
(+1.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
All News about Beigene Ltd ADR
Five Best And Worst Performing Healthcare Stocks In December 2022
January 22, 2023
Via Talk Markets
4 Analysts Have This to Say About BeiGene
January 20, 2023
Via Benzinga
Via Benzinga
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
Via Benzinga
Via Benzinga
BeiGene Earnings Perspective: Return On Capital Employed
December 12, 2022
Via Benzinga
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Via Benzinga
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Via Benzinga
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
January 19, 2023
From BeiGene
Via Business Wire
BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug List
January 18, 2023
From BeiGene
Via Business Wire
Via Talk Markets
From BeiGene
Via Business Wire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.